These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 29245)

  • 41. Combined transcriptional and translational targeting of EWS/FLI-1 in Ewing's sarcoma.
    Mateo-Lozano S; Gokhale PC; Soldatenkov VA; Dritschilo A; Tirado OM; Notario V
    Clin Cancer Res; 2006 Nov; 12(22):6781-90. PubMed ID: 17121899
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Experimental approach for the search of effective drug combination in cancer chemotherapy.
    Bello JL; Kariev NI; Mainardi JV; Betancourt M; Lage A; Barroso MC; Alfonso L
    Neoplasma; 1982; 29(1):65-71. PubMed ID: 7070556
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Enzyme changes induced in normal and malignant tissues with chemical agents. IV. Effect of alpha-peltatin on glucose utilization by sarcoma 37 and on the adenosinetriphosphatase, hexokinase, aldolase, and pyridine nucleotide levels of sarcoma 37.
    WARAVDEKAR VS; PARADIS AD; LEITER J
    J Natl Cancer Inst; 1955 Aug; 16(1):31-9. PubMed ID: 13243111
    [No Abstract]   [Full Text] [Related]  

  • 44. [Cancerostasis by means of alkylating cytostatics and tumor glycolysis in vivo].
    Schmidt CG
    Klin Wochenschr; 1967 Feb; 45(4):188-91. PubMed ID: 5586139
    [No Abstract]   [Full Text] [Related]  

  • 45. Damage induced in sarcoma 37 with podophyllin, podophyllotoxin alpha-peltatin, beta-peltatin, and quercetin.
    LEITER J; DOWNING V; HARTWELL JL; SHEAR MJ
    J Natl Cancer Inst; 1950 Jun; 10(6):1273-93. PubMed ID: 14774701
    [No Abstract]   [Full Text] [Related]  

  • 46. Biotransformation of a dibenzylbutanolide to podophyllotoxin analogues by shoot cultures of Haplophyllum patavinum.
    Puricelli L; Caniato R; Delle Monache G
    Chem Pharm Bull (Tokyo); 2003 Jul; 51(7):848-50. PubMed ID: 12843593
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of alpha-peltatin, beta-peltatin, podophyllotoxin on lymphomas and other transplanted tumors.
    GREENSPAN EM; LEITER J; SHEAR MJ
    J Natl Cancer Inst; 1950 Jun; 10(6):1295-1333. PubMed ID: 14774702
    [No Abstract]   [Full Text] [Related]  

  • 48. The cytological effect of chemicals on ascites sarcomas. III. Damage induced by podophyllotoxin, alpha-peltatin, beta-peltatin and quercetin.
    TANAKA T; KANO K; TONOMURA A; OKADA TA; UMETANI M
    Gan; 1955 Mar; 46(1):15-26. PubMed ID: 14380575
    [No Abstract]   [Full Text] [Related]  

  • 49. Crystal and molecular structure of beta-peltatin a methyl ether.
    Arora SK; Bates RB; Grady RA
    J Org Chem; 1975 Jan; 40(1):28-31. PubMed ID: 1133598
    [No Abstract]   [Full Text] [Related]  

  • 50. Naloxone as an adjuvant in chemotherapy of an experimental tumor.
    Sjölander U; Ronquist G; Hugosson R
    J Cancer Res Clin Oncol; 1984; 108(2):246-8. PubMed ID: 6470032
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Experiments to increase the selectivity of tumor chemotherapy by means of in vivo activation of transport forms of cancerostatics by exogenous enzymes.
    Graffi A; Arnold W; Sydow G; Schwabe K; Arndt D; Pehl E
    Neoplasma; 1978; 25(4):377-84. PubMed ID: 29245
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Distribution studies of alpha-L-arabinofuranosidase already unstable at pH 7.0 (37 degrees C) in tumor-bearing mice in connection with its possible use to enhance the selectivity of the chemotherapy of malignant tumors].
    Butschak G; Schulze B; Küster A; Niederhausen T; Niemeyer U; Graffi A
    Arch Geschwulstforsch; 1990; 60(3):193-200. PubMed ID: 2369282
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Selective tumor DNA synthesis inhibition: in vivo prodrug activation by an exogenous enzyme.
    Tschiersch B; Schwabe K; Sydow G; Graffi A
    Cancer Treat Rep; 1977 Nov; 61(8):1489-93. PubMed ID: 21745
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Selective variations in toxicity of new transport forms of carcinostatics produced by exogenous enzymes. 2. Beta-peltatin A-alpha-L-arabinofuranoside and alpha-L-arabinofuranosidase].
    Tschiersch B; Schwabe K; Sydow G; Graffi A
    Pharmazie; 1978 Jun; 33(6):358-61. PubMed ID: 28536
    [No Abstract]   [Full Text] [Related]  

  • 55. [Pharmacokinetic studies of the activity of a pH-labile alpha-L-arabinofuranosidase following i.v. injection into tumor-bearing mice].
    Butschak G; Schulze B; Küster A; Niederhausen T; Niemeyer U; Graffi A
    Arch Geschwulstforsch; 1989; 59(5):325-31. PubMed ID: 2589931
    [TBL] [Abstract][Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.